We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Polarean Imaging Ltd (POLX) ORD GBP0.00037

Sell:3.75p Buy:3.90p 0 Change: 0.075p (1.92%)
Market closed Prices as at close on 23 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:3.75p
Buy:3.90p
Change: 0.075p (1.92%)
Market closed Prices as at close on 23 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:3.75p
Buy:3.90p
Change: 0.075p (1.92%)
Market closed Prices as at close on 23 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Polarean Imaging PLC is a medical-imaging technology company, with an investigational drug-device combination product for magnetic resonance imaging (MRI). The Company and its subsidiary company operate as investigational drug-device combination companies operating in the high-resolution medical imaging research space. The Company develops equipment that enables existing MRI systems to achieve an improved level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation. 129Xe gas is being studied for visualization of gas exchange regionally in the smallest airways of the lungs, across the alveolar tissue membrane, and into the pulmonary bloodstream. The Company’s technology provides an investigational diagnostic approach, offering a non-invasive and radiation-free functional imaging platform. It operates in Canada, Germany, United Kingdom and United States. The Company’s subsidiary is Polarean, Inc.

Contact details

Address:
2500 Meridian Pkwy #175
DURHAM
27713
United States
Telephone:
+1 (0919) 2067900
Website:
https://polarean.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 07 September 2023 07/09/23
AGM 28 June 2023 28/06/23
Final results 26 May 2023 26/05/23
Annual report 26 May 2023 26/05/23

General stock information

EPIC:
POLX
ISIN:
GB00BF3DT583
Market cap:
£8.27 million
Shares in issue:
216.26 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Christopher Von Jako
    Chief Executive Officer, Director
  • Charles Osborne
    Chief Financial Officer, Executive Director
  • Bastiaan Driehuys
    Chief Technology Officer, Executive Director
  • Stephen Austin
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.